Article
CScape-somatic: distinguishing driver and passenger point mutations in the cancer genome.
Bioinformatics (Oxford, England) - 1 Jun 2020
Rogers Mark F, Gaunt Tom R, Campbell Colin
Abstract excerpt
MOTIVATION: Next-generation sequencing technologies have accelerated the discovery of single nucleotide variants in the human genome, stimulating the development of predictors for classifying which of these variants are likely functional in disease, and which neutral. Recently, we proposed CScape, a method for discriminating between cancer driver mutations and presumed benign variants. For the neutral class, this...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
